Magnetic resonance imaging in the assessment of ventricular remodeling and viability

Current Heart Failure Reports

Volumn 5, Issue 1, 2008, Pages 5-10

  Jerosch Herold, Michael ^a   Kwong, Raymond Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; METOPROLOL; THALLIUM 201; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; HEART VENTRICLE VOLUME; HEART VENTRICLE WALL; HUMAN; MITRAL VALVE REGURGITATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENSITIVITY AND SPECIFICITY; STRESS STRAIN RELATIONSHIP; WALL STRESS; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; MALE; METHODOLOGY; PHYSIOLOGY;

FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; TISSUE SURVIVAL; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 47149092608     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-008-0002-4     Document Type: Review

References (38)

1. Pelliccia A: Athlete's heart and hypertrophic cardiomyopathy. Curr Cardiol Rep 2000, 2:166-171.
2. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
3. Cohn JN, Ferrari R, Sharpe N: Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000, 35:569-582.
4. Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
5. Friedrich J, Apstein CS, Ingwall JS: 31P nuclear magnetic resonance spectroscopic imaging of regions of remodeled myocardium in the infarcted rat heart. Circulation 1995, 92:3527-3538.
6. Neubauer S: Cardiac magnetic resonaPce spectroscopy: potential clinical applications. Herz 2000, 25:452-460.
7. Zhang J, Wilke N, Wang Y, et al.: Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31 P-MRS study. Circulation 1996, 94:1089-1100.
8. Francois CJ, FienM DS, Shors SM, Fin JP: Left ventricular mass: manual and automatic segmentation of true FISP and FLASH cine MR images in dogs and pigs. Radiology 2004, 230:389-395.
9. Stillman AE, Wilke N, Jerosch-Herold M: Use of an intravascular T1 contrast agent to improve MR cine myocardial-blood pool definition in man. J Magn Reson Imaging 1997, 7:765-767.
10. Pennell DJ, Underwood SR, Longmore DB: Improved cine MR imaging of left ventricular wall motion with gadopentetate dimeglumine. J Magn Reson Imaging 1993, 3:13-19.
11. Rehr RB, Malloy CR, Filipchuk NG, Peshock RM: Left ventricular volumes measured by MR imaging. Radiology 1985, 156:717-719.
12. Shors SM, Cotts WG, Pavlovic-Surjancev B, et al.: Heart failure: evaluation of cardiopulmonary transit times with time-resolved MR angiography. Radiology 2003, 229:743-748.
13. Debatin JF, Nadel SN, Paolini JF, et al.: Cardiac ejection fraction: phantom study comparing cine MR imaging, radionuclide blood pool imaging, and ventriculography. J Magn Reson Imaging 1992, 2:135-142.
14. Sechtem U, Pflugfelder PW, Gould RG, et al.: Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology 1987, 163:97-702.
15. Grothues F, Smith GC, Moon JC, et al.: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002, 90:29-34.
16. Bellenger NG, Davies LC, Francis JM, et al.: Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000, 2:271-278.
17. Groenning BA, Nilsson JC, Sondergaard L, et al.: Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 2000, 36:2072-2080.
18. Kono T, Sabbah HN, Rosman H, et al.: Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992, 20:1594-1598.
19. Lamas GA, Vaughan DE, Parisi AF, Pfeffer MA: Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol 1989, 63:117-1173.
20. Mann DL: Left ventricular sDze and shape: determinants of mechanical signal transduction pathways. Heart Fail Rev 2005, 10:95-100.
21. Balzer P, Furber A, Delepine S, et al.: Regional assessment of wall curvature and wall stress in left ventricle with magnetic resonance imaging. Am J Physiol 1999, 277:H901-H910.
22. DeAnda A Jr, Komeda M, Moon MR, et al.: Estimation of regional left ventricular wall stresses in intact canine hearts. Am J Physiol 1998, 275:H1879-H1885.
23. Grossman W, Braunwald E, Mann T, et al.: Contractile state of the left ventricle in man as evaluated from endsystolic pressure-volume relations. Circulation 1977, 56:845-852.
24. Wollmuth JR, Bree DR, Cupps BP, et al.: Left ventricular wall stress in patients with severe aortic insufficiency with finite element analysis. Ann Thorac Surg 2006, 82:840-846.
25. Blom AS, Mukherjee R, Pilla JJ, et al.: Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation 2005, 112:1274-1283.
26. Lund GK, Stork A, Muellerleile K, et al.: Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imaging. Radiology 2007, 245:95-102.
27. Judd RM, Lugo-Olivieri CH, Arai M, et al.: Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995, 92:1902-1910.
28. Fieno DS, Hillenbrand HB, Rehwald WG, et al.: Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol 2004, 43:2124-2131.
29. Bello D, Shah DJ, Farah GM, et al.: Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003, 108:1945-1953.
30. Orn S, Manhenke C, Anand IS, et al.: Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction. Am J Cardiol 2007, 99:1109-1114.
31. Kwong RY, Chan AK, Brown KA, et al.: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113:2733-2743. [Published erratum appears in Circulation 2006, 114:e365.]
32. Kitagawa K, Sakuma H, Hirano T, et al.: Acute myocardial infarction: myocardial viability assessment in patients early thereafter: Comparison of contrast-enhanced MR imaging with resting (201)Tl SPECT. Single photon emission computed tomography. Radiology 2003, 226:138-144.
33. Mahrholdt H, Wagner A, Holly TA, et al.: Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002, 106:2322-2327.
34. Thiele H, Kappl MJ, Conradi S, et al.: Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 2006, 47:1641-1645.
35. Wu KC, Zerhouni EA, Judd RM, et al.: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998, 97:765-772.
36. Baks T, van Geuns RJ, Biagini E, et al.: Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. J Am Coll Cardiol 2006, 47:40-44.
37. Nazarian S, Roguin A, Zviman MM, et al.: Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006, 114:1277-1284.
38. Brodoefel H, Klumpp B, Reimann A, et al.: Late myocardial enhancement assessed by 64-MSCT in reperfused porcine myocardial infarction: diagnostic accuracy of low-dose CT protocols in comparison with magnetic resonance imaging. Eur Radiol 2007, 17:475-483.